References
- Ghosh D, Sengupta J. Another look at the issue of peri-implantation oestrogen. Hum Reprod 1995;10:1–2.
- Edgar DH. Oestrogen and human implantation. Hum Reprod 1995;10:2–4.
- De Zeigler D. Hormonal control of endometrial receptivity. Hum Reprod 1995;10:4–7.
- Simon C, Cano F, Valbuena D, Remohi J, Pellicer A. Clinical evidence for a detrimental effect on uterine receptivity of high serum oestradiol concentrations in high and normal responder patients. Hum Reprod 1995;9:2432–2437.
- Chenette PE, Sauer MV, Paulson RJ. Very high estradiol levels are not detrimental to clinical outcome of in vitro fertilization. Fertil Steril 1990;54:858–863.
- Paulson RJ, Sauer MV, Lobo RA. Embryo implantation after human in vitro fertilization: importance of endometrial reseptivity. Fertil Steril 1990;53:870–874.
- Loumaye E, Engrand P, Howles CM, O'Dea L. Assesment of the role of serum luteinizing hormone and estradiol response to follicle-stimulating hormone on in vitro fertilization treatment outcome. Fertil Steril 1997;67:889–899.
- Yang J-H, Chen H-F, Lien Y-R, Chen S-U, Ho H-N, Yang Y-S. Elevated E2/oocyte ratio in women undergoing IVF and tubal ET. J Reprod Med 2001;46:434–438.
- Orvieto R, Zohav E, Scharf S, Rabinson J, Meltcer S, Anteby E, Homburg R. The influence of estradiol/oocyte ratios on the outcome of controlled ovarian stimulation for in vitro fertilization. Gynecol Endocrinol 2007;23:72–75.
- Cummins JM, Bren TM, Harrison KL, Shaw JM, Wilson LM, Hennessey JF. A formula for scoring human embryo growth rates in in vitro fertilization: its value in predicting pregnancy and in comparision with visual estimates of embryo quality. J In Vitro Fert Embryo Transf 1986;3:284–295.
- Ng EHY, Yeung WSB, Lau EYL, So WWK, Ho PC. High serum oestradiol concentrations in fresh IVF cycles do not impair implantation and pregnancy rates in subsequent frozen-thawed embryo transfer cycles. Hum Reprod 2000;15:250–255.
- Sharara FI, McClamrock HD. High estradiol levels and high oocyte yield are not detrimental to in vitro fertilization outcome. Fertil Steril 1999;72:401–405.
- Chen Q-J, Sun X-X, Li L, Gao X-H, Wu Y, Gemzell-Danielsson K, Cheng L-N. Effects of ovarian high response on implantation and pregnancy outcome during controlled ovarian hyperstimulation(with GnRH agonist and rFSH). Acta Obstet Gynecol 2007;86:849–854.
- Kosmas IP, Kolibianakis EM, Devroey P. Association of estradiol levels on the day of HCG administration and pregnancy achievement in IVF: a systemativ review. Hum Reprod 2004;19:2446–2453.
- Andersen AN, Devroey P, Arce J-C. Clinical outcome following stimulation with highly purified Hmg or recombinant FSH in patients undergoing IVF: a randomized assessor-blind controlled trial. Hum Reprod 2006;21:3217–3227.
- Filicori M, Cognigni GE, Gamberini E, Parmegiani L, Troilo E, Roset B. Efficacy of low-dose human chorionic gonadtropin alone to complete controlled ovarian stimulation. Fertil Steril 2005;84:394–401.
- Dimitry ES, Oskarsson T, Conanghan J, Margara R, Winston RML. Beneficial effects of a 24 h delay in human chorionic gonadotropin administration during in-vitro fertilization. Hum Reprod 1991;6:944–946.
- Kolibianakis EM, Albano C, Camus M, Tournaye H, Van Steirteghem AC, Devroey P. Prolongation of the follicular phase in in vitro fertilization results in a lower ongoing pregnancy rate in cycles stimulated with recombinant follicle-stimulating hormone and gonadotropin-releasing hormone antagonists. Fertil Steril 2004;82:102–107.
- Kolibianakis EM, Bourgain C, Papanikolaou EG, Camus M, Tournaye H, Van Steirteghem AC, Devroey P. Prolongation of the follicular phase by delaying HCG administration results in a higher incidence of endometrial advancement on the day of oocyte retrieval in GnRH antagonist cycles. Hum Reprod 2005;20:2453–2456.